471 related articles for article (PubMed ID: 20075151)
1. Radiation exposure and circulatory disease risk: Hiroshima and Nagasaki atomic bomb survivor data, 1950-2003.
Shimizu Y; Kodama K; Nishi N; Kasagi F; Suyama A; Soda M; Grant EJ; Sugiyama H; Sakata R; Moriwaki H; Hayashi M; Konda M; Shore RE
BMJ; 2010 Jan; 340():b5349. PubMed ID: 20075151
[TBL] [Abstract][Full Text] [Related]
2. High Excess Risk of Heart Disease Mortality among Hiroshima Atomic Bomb Male Survivors Exposed Near the Hypocenter.
Hara N; Satoh K; Otani K; Kawakami H; Ohtaki M
Hiroshima J Med Sci; 2016 Sep; 65(2):45-51. PubMed ID: 29989684
[TBL] [Abstract][Full Text] [Related]
3. Solid cancer incidence in atomic bomb survivors: 1958-1998.
Preston DL; Ron E; Tokuoka S; Funamoto S; Nishi N; Soda M; Mabuchi K; Kodama K
Radiat Res; 2007 Jul; 168(1):1-64. PubMed ID: 17722996
[TBL] [Abstract][Full Text] [Related]
4. Solid Cancer Incidence among the Life Span Study of Atomic Bomb Survivors: 1958-2009.
Grant EJ; Brenner A; Sugiyama H; Sakata R; Sadakane A; Utada M; Cahoon EK; Milder CM; Soda M; Cullings HM; Preston DL; Mabuchi K; Ozasa K
Radiat Res; 2017 May; 187(5):513-537. PubMed ID: 28319463
[TBL] [Abstract][Full Text] [Related]
5. Comparison of All Solid Cancer Mortality and Incidence Dose-Response in the Life Span Study of Atomic Bomb Survivors, 1958-2009.
Brenner AV; Preston DL; Sakata R; Cologne J; Sugiyama H; Utada M; Cahoon EK; Grant E; Mabuchi K; Ozasa K
Radiat Res; 2022 May; 197(5):491-508. PubMed ID: 35213725
[TBL] [Abstract][Full Text] [Related]
6. Exposure to ionizing radiation and development of bone sarcoma: new insights based on atomic-bomb survivors of Hiroshima and Nagasaki.
Samartzis D; Nishi N; Hayashi M; Cologne J; Cullings HM; Kodama K; Miles EF; Funamoto S; Suyama A; Soda M; Kasagi F
J Bone Joint Surg Am; 2011 Jun; 93(11):1008-15. PubMed ID: 21984980
[TBL] [Abstract][Full Text] [Related]
7. Heart Disease Mortality in the Life Span Study, 1950-2008.
Takahashi I; Shimizu Y; Grant EJ; Cologne J; Ozasa K; Kodama K
Radiat Res; 2017 Mar; 187(3):319-332. PubMed ID: 28170314
[TBL] [Abstract][Full Text] [Related]
8. Cancer and non-cancer effects in Japanese atomic bomb survivors.
Little MP
J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804
[TBL] [Abstract][Full Text] [Related]
9. Risk of death among children of atomic bomb survivors after 62 years of follow-up: a cohort study.
Grant EJ; Furukawa K; Sakata R; Sugiyama H; Sadakane A; Takahashi I; Utada M; Shimizu Y; Ozasa K
Lancet Oncol; 2015 Oct; 16(13):1316-23. PubMed ID: 26384241
[TBL] [Abstract][Full Text] [Related]
10. Studies of the mortality of atomic bomb survivors, Report 14, 1950-2003: an overview of cancer and noncancer diseases.
Ozasa K; Shimizu Y; Suyama A; Kasagi F; Soda M; Grant EJ; Sakata R; Sugiyama H; Kodama K
Radiat Res; 2012 Mar; 177(3):229-43. PubMed ID: 22171960
[TBL] [Abstract][Full Text] [Related]
11. Radiation and Risk of Liver, Biliary Tract, and Pancreatic Cancers among Atomic Bomb Survivors in Hiroshima and Nagasaki: 1958-2009.
Sadakane A; French B; Brenner AV; Preston DL; Sugiyama H; Grant EJ; Sakata R; Utada M; Cahoon EK; Mabuchi K; Ozasa K
Radiat Res; 2019 Sep; 192(3):299-310. PubMed ID: 31291162
[TBL] [Abstract][Full Text] [Related]
12. Exposure to Atomic Bomb Radiation and Age-Related Macular Degeneration in Later Life: The Hiroshima-Nagasaki Atomic Bomb Survivor Study.
Itakura K; Takahashi I; Nakashima E; Yanagi M; Kawasaki R; Neriishi K; Wang JJ; Wong TY; Hida A; Ohishi W; Kiuchi Y
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5401-6. PubMed ID: 26275137
[TBL] [Abstract][Full Text] [Related]
13. Mortality Analysis of the Life Span Study (LSS) Cohort Taking into Account Multiple Causes of Death Indicated in Death Certificates.
Takamori A; Takahashi I; Kasagi F; Suyama A; Ozasa K; Yanagawa T
Radiat Res; 2017 Jan; 187(1):20-31. PubMed ID: 27992282
[TBL] [Abstract][Full Text] [Related]
14. Long-term radiation-related health effects in a unique human population: lessons learned from the atomic bomb survivors of Hiroshima and Nagasaki.
Douple EB; Mabuchi K; Cullings HM; Preston DL; Kodama K; Shimizu Y; Fujiwara S; Shore RE
Disaster Med Public Health Prep; 2011 Mar; 5 Suppl 1(0 1):S122-33. PubMed ID: 21402804
[TBL] [Abstract][Full Text] [Related]
15. Thyroid Dysfunction and Autoimmune Thyroid Diseases Among Atomic Bomb Survivors Exposed in Childhood.
Imaizumi M; Ohishi W; Nakashima E; Sera N; Neriishi K; Yamada M; Tatsukawa Y; Takahashi I; Fujiwara S; Sugino K; Ando T; Usa T; Kawakami A; Akahoshi M; Hida A
J Clin Endocrinol Metab; 2017 Jul; 102(7):2516-2524. PubMed ID: 28472357
[TBL] [Abstract][Full Text] [Related]
16. Dose-responses for mortality from cerebrovascular and heart diseases in atomic bomb survivors: 1950-2003.
Schöllnberger H; Eidemüller M; Cullings HM; Simonetto C; Neff F; Kaiser JC
Radiat Environ Biophys; 2018 Mar; 57(1):17-29. PubMed ID: 29222678
[TBL] [Abstract][Full Text] [Related]
17. Lung, Laryngeal and Other Respiratory Cancer Incidence among Japanese Atomic Bomb Survivors: An Updated Analysis from 1958 through 2009.
Cahoon EK; Preston DL; Pierce DA; Grant E; Brenner AV; Mabuchi K; Utada M; Ozasa K
Radiat Res; 2017 May; 187(5):538-548. PubMed ID: 28323575
[TBL] [Abstract][Full Text] [Related]
18. Ionizing radiation exposure and the development of soft-tissue sarcomas in atomic-bomb survivors.
Samartzis D; Nishi N; Cologne J; Funamoto S; Hayashi M; Kodama K; Miles EF; Suyama A; Soda M; Kasagi F
J Bone Joint Surg Am; 2013 Feb; 95(3):222-9. PubMed ID: 23389785
[TBL] [Abstract][Full Text] [Related]
19. Radiation and cancer risk in atomic-bomb survivors.
Kodama K; Ozasa K; Okubo T
J Radiol Prot; 2012 Mar; 32(1):N51-4. PubMed ID: 22394591
[TBL] [Abstract][Full Text] [Related]
20. High Initial-dose Dependency of Cerebrovascular Disease Mortality among Female Survivors of the Hiroshima Atomic Bomb Exposed in Teens: A Cohort Study, 1970-2010.
Matsuba J; Otani K; Satoh K; Kawakami H; Ohtaki M
Hiroshima J Med Sci; 2016 Sep; 65(2):35-43. PubMed ID: 29989683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
